Actively Recruiting

Phase Not Applicable
Age: 60Years - 85Years
All Genders
NCT07517497

The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs

Led by Astana Medical University · Updated on 2026-04-08

60

Participants Needed

1

Research Sites

143 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A medical professional trained in the procedure and use of the device will conduct the vibroacoustic therapy session. He will also take blood samples. In the control group, patients will undergo vibroacoustic pulmonary therapy in the "Pneumonia" mode, and in the control group, in the "Prevention" mode. Vibroacoustic pulmonary therapy will be conducted over a period of 5 days. A similar algorithm of actions is planned for both groups. VALT sessions will be conducted 4-6 times a day for 5 minutes in combination with treatment according to the protocol for the use of "Vibroacoustic Therapy" of the lungs of the Ministry of Health of the Republic of Kazakhstan. The device's emitters will be applied to the affected areas of the lungs. Since the device has long cords for the emitters and is portable, it is not difficult to change the patient's position and does not require their active participation, which is important for patients on ventilators and with limited mobility.

CONDITIONS

Official Title

The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs

Who Can Participate

Age: 60Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Respiratory failure
  • Hip fracture
  • Injury Severity Score no higher than 8 points
  • Age between 60 and 85 years
Not Eligible

You will not qualify if you...

  • All contraindications for the use of the device
  • Terminal condition
  • Shock
  • Paradoxical pathological breathing
  • Hypertensive crisis
  • Severe hypocoagulation with risk of bleeding
  • Severe hypercoagulation with risk of thrombus or embolus migration
  • Acute cerebrovascular accident within 1-3 days
  • Brain edema
  • Multiple purulent or burn wounds in the treatment area
  • Unstable rib fractures
  • Pneumomediastinum or subcutaneous emphysema of the chest
  • Osteomyelitis of ribs or thoracic spine
  • Spinal fracture without orthopedic fixation
  • Chest or abdominal trauma with bleeding
  • Injury Severity Score greater than 8 points
  • Decompensated concomitant diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Astana medical university

Astana, Kazakhstan, 010000

Actively Recruiting

Loading map...

Research Team

A

Assema Bekniyazova

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here